期刊文献+

miR-495-3p在甲状腺乳头状癌组织中的表达水平及与手术预后的关系

Expression level of miR-495-3p in papillary thyroid carcinoma and its relationship with surgical prognosis
下载PDF
导出
摘要 探究与分析miR-495-3p在甲状腺乳头状癌组织中的表达水平及与手术预后的关系。回顾性分析中国人民解放军联勤保障部队第九一〇医院2020年3月—2022年2月收治的甲状腺乳头状癌90例患者的临床资料,全部患者均获取了肿瘤组织标本及癌旁正常甲状腺组织标本,通过采用实时定量反转录聚合酶链反应(RT-qPCR)技术,对肿瘤组织及癌旁正常甲状腺组织中mi-R495-3p表达水平进行测量,分析mi-R495-3p表达水平与甲状腺乳头状癌临床病理特征之间的关系,采用多元Cox逐步回归分析探讨影响甲状腺乳头状癌患者手术预后的影响因素。甲状腺乳头状癌组织中mi-R495-3p表达水平(1.45±0.54)明显高于癌旁正常甲状腺组织(0.76±0.17),差异有统计学意义(P<0.05)。TNM分期为Ⅲ~Ⅳ期患者的mi-R495-3p表达水平要明显高于Ⅰ~Ⅱ期患者,发生腺外浸润患者的mi-R495-3p表达水平要明显未发生腺外浸润患者,发生了淋巴结转移的mi-R495-3p表达水平要明显高于未发生淋巴结转移患者,淋巴结侵犯数目在3个以上患者mi-R495-3p表达水平要明显高于淋巴结侵犯数目为1至3个、0个患者,差异均有统计学意义(P<0.05)。行Logistic回归分析可见,PTC组织中的mi-R495-3p表达水平与TNM分期、腺外浸润、淋巴结转移、淋巴结侵犯数目相关(P<0.05)。mi-R495-3p高表达组发生原位复发的患者比例要明显高于mi-R495-3p低表达组,差异有统计学意义(P<0.05)。mi-R495-3p在甲状腺乳头状癌组织当中可表现出较高的表达水平,与甲状腺乳头状癌患者的肿瘤直径、TNM分期、腺外浸润、淋巴结侵犯数具有密切的关系;mi-R495-3p表达水平较高的患者术后更加容易发生原位复发。
作者 郑晓宏 邱怀鹏 袁园 黄惠玲 魏开鹏 张少波 ZHENG Xiao-hong;QIU Huai-peng;YUAN Yuan;HUANG Hui-ling;WEI Kai-peng;ZHANG Shao-bo
出处 《中国现代普通外科进展》 CAS 2024年第7期571-574,共4页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献15

二级参考文献64

  • 1廖秋林,张卫云,张宏斌,崔华娟,陈炳旭,张伟,陈晓东.鼻咽癌患者血清sICAM-1和SAA1及HSP70检测临床意义分析[J].中华肿瘤防治杂志,2013,20(2):110-112. 被引量:16
  • 2ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 3SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:74
  • 4Elisei R, Molinaro E, Agate L, et al. Are the clinical and pathological features of differentiated thyroid carcinoma re- ally changed over the last 35 years study on 4187 patients from asinde Italian institution to answer this question[ J]. J Clin Endoerinol Metab,2010,95(4) :1516-1527. 被引量:1
  • 5Jensen K,Patel A,Hopeda V,et al. Dynamic changes in E- cadherin gene promoter methylation dudng rnetastatic pro- gression in papillary thyroid cancer [ J ]. Exp Therap Med, 2011 ( 3 ) :457-462. 被引量:1
  • 6Chaychi L, Belbruno K, Golding A, et al. Unusual manifes- tation of parathyroid carcinoma in the setting of papillary thyroid cancer [J ). Endocr Pract, 2010,16 ( 4 ) : 664-668. 被引量:1
  • 7Hayashi N,Kitaoka M. Fine. needle aspiration biopsy of the thyroid nodule: uses and limitations [ J]. Nippon Rinsho, 2007,65 ( 11 ) : 2003-2007. 被引量:1
  • 8Lin CI, Whang EE, Donner DB, et al. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enilances both chemosensitivity and radiosensitivity in papillary thyroid cancer [ J]. Mol Cancer Res, 2009, 7 (10) :1655-1662. 被引量:1
  • 9Kaczka K, Fendler W, Borowiee M, et al. Lymph node me- tastases in papillary thyroid cancer detected by quantitative real-time polymerase chain reaction for thyroglobulin and eytokeratine-19[ J]. Pol J Pathol,2013,64(2) :90-95. 被引量:1
  • 10Park do J,Lim JA, Kim TH, et al. Serum thyroglobulin level measured after thyroxine withdrawal is usefial to predict fur- ther recurrence in whole body scan-negative papillary thy- roid cancer patients after reoperation [J]. Endocr J, 2012, 59(11 ) :1021-1030. 被引量:1

共引文献743

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部